PREVAIL is a clinical trial designed to determine whether an investigational new drug, obicetrapib, can reduce the risk of cardiovascular events (like a heart attack or stroke) in individuals with Atherosclerotic Cardiovascular Disease (ASCVD).
See if You Qualify
